Trial Profile
Phase II study using thalidomide for the treatment of amyotrophic lateral sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2007
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 20 Nov 2007 Status changed from recruiting to completed.
- 29 Aug 2006 New trial record.